Alphabet Inc.
CIK 1652044 · View on SEC EDGAR ↗
- Portfolio value
- $99.1B
- Positions
- 28
- As of
- June 30, 2026
Portfolio value QoQ: +2376.3% 13F does not disclose cash
- Top 10 holdings weight
- 99.54%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.15% Est. buys $94,362,350,832 · sells $78,519,324
Median holding: 5.0 quarters Tracked Q4 2024–Q2 2026 · 53.8% still held
- New positions
- 3
- Increased
- 0
- Decreased
- 4
- Closed
- 1
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +84.4% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 96.8% · Options excluded: 0.0%
Sector breakdown
Full portfolio 28 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: 84615Q103) | $94,176,237,970 | 95.07% | 551,189,500 | Up ×1 | |||
| PL Planet Labs PBC Class A Common Stock | $1,167,795,849 | 1.18% | 35,248,893 | $182,589,267 | |||
| ASTS AST SpaceMobile, Inc. - Class A Common Stock | $794,718,166 | 0.80% | 8,943,486 | $53,571,481 | |||
| CME CME Group Inc. - Class A Common Stock | $769,376,137 | 0.78% | 3,484,020 | $-259,629,170 | |||
| ARM Arm Holdings plc - American Depositary Shares | $695,235,183 | 0.70% | 1,960,784 | $398,607,779 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $551,842,806 | 0.56% | 2,946,619 | $231,644,750 | Down ×1 | ||
| FRSH Freshworks Inc. - Class A Common Stock | $144,992,003 | 0.15% | 14,327,273 | $29,944,001 | |||
| Unknown issuer (CUSIP: 698955101) | $134,646,660 | 0.14% | 4,919,498 | Up ×1 | |||
| TEM Tempus AI, Inc. - Class A Common Stock | $89,855,339 | 0.09% | 1,551,102 | $19,714,507 | |||
| GTLB GitLab Inc. - Class A Common Stock | $83,185,457 | 0.08% | 2,724,712 | $24,222,689 | |||
| PATH UiPath, Inc. Class A Common Stock | $76,463,243 | 0.08% | 7,034,337 | $-1,617,898 | |||
| LIFE Ethos Technologies Inc. - Class A Common Stock | $65,714,037 | 0.07% | 3,622,604 | $23,601,394 | Down ×1 | ||
| PRME Prime Medicine, Inc. - Common Stock | $61,115,618 | 0.06% | 16,562,498 | $3,478,125 | |||
| Unknown issuer (CUSIP: 31556C106) | $51,466,202 | 0.05% | 1,760,732 | Up ×1 | |||
| Unknown issuer (CUSIP: 70450C101) | $44,781,250 | 0.05% | 3,125,000 | $-21,906,250 | |||
| MAZE Maze Therapeutics, Inc. - Common Stock | $41,435,317 | 0.04% | 1,388,583 | $-13,886 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $26,381,643 | 0.03% | 1,410,029 | $10,818,122 | Down ×1 | ||
| BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | $21,512,220 | 0.02% | 2,823,126 | $-3,754,758 | |||
| OSCR Oscar Health, Inc. Class A Common Stock | $13,746,298 | 0.01% | 481,988 | $8,217,896 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $11,037,449 | 0.01% | 321,604 | $3,373,626 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $10,352,638 | 0.01% | 241,264 | $646,587 | |||
| SANA Sana Biotechnology, Inc. - Common Stock | $9,815,625 | 0.01% | 2,812,500 | $1,715,625 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $9,013,871 | 0.01% | 372,474 | $-2,242,453 | Down ×3 | ||
| LYEL Lyell Immunopharma, Inc. - Common Stock | $4,120,247 | 0.00% | 293,256 | $-1,762,468 | |||
| FIG Figma, Inc. Class A Common Stock | $3,899,878 | 0.00% | 215,582 | $-657,525 | |||
| SPRO Spero Therapeutics, Inc. - Common Stock | $1,966,854 | 0.00% | 889,979 | $-115,697 | |||
| HYPR Hyperfine, Inc. - Class A Common Stock | $1,213,272 | 0.00% | 898,720 | $242,654 | |||
| AUTL Autolus Therapeutics plc - American Depositary Shares | $1,117,219 | 0.00% | 698,262 | $153,617 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: 84615Q103) | $94,176,237,970 | 551,189,500 | 95.07% |
| Unknown issuer (CUSIP: 698955101) | $134,646,660 | 4,919,498 | 0.14% |
| Unknown issuer (CUSIP: 31556C106) | $51,466,202 | 1,760,732 | 0.05% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ARM | Price move only | +0 | +$398.6M |
| CME | Price move only | +0 | -$259.6M |
| RVMD | Trimmed | -346K | +$231.6M |
| PL | Price move only | +0 | +$182.6M |
| ASTS | Price move only | +0 | +$53.6M |
| FRSH | Price move only | +0 | +$29.9M |
| GTLB | Price move only | +0 | +$24.2M |
| LIFE | Trimmed | -148K | +$23.6M |
| — | Price move only | +0 | -$21.9M |
| TEM | Price move only | +0 | +$19.7M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| MTSR | Dec. 31, 2025 | 3,783,528 | $197,992,020 | No longer tracked |
| VERV | Sept. 30, 2025 | 12,168,489 | $136,652,131 | No longer tracked |
| DXCM | March 31, 2026 | 1,036,937 | $68,821,509 | 45.0% |
| CRWD | June 30, 2025 | 74,230 | $26,172,013 | -61.1% |
| DNTH | Dec. 31, 2025 | 208,697 | $8,212,227 | 169.4% |
| DM | June 30, 2025 | 1,104,871 | $5,424,917 | No longer tracked |
| LYELXXXX | June 30, 2025 | 5,865,125 | $3,167,168 | No longer tracked |
| WGS | March 31, 2026 | 22,711 | $2,953,793 | 26.1% |
| FHTX | Dec. 31, 2025 | 500,901 | $2,449,406 | 29.3% |
| EXAS | March 31, 2026 | 23,205 | $2,356,700 | No longer tracked |
| TSHA | Dec. 31, 2025 | 640,882 | $2,095,684 | 10.9% |
| TCRX | Dec. 31, 2025 | 1,077,080 | $1,960,286 | -24.9% |
| BRNS | Dec. 31, 2025 | 1,513,644 | $1,892,055 | -14.0% |
| KRON | June 30, 2025 | 1,438,232 | $1,193,733 | No longer tracked |
| GUTS | Dec. 31, 2025 | 662,584 | $1,053,509 | -68.2% |
| BHILQ | March 31, 2025 | 438,635 | $864,111 | No longer tracked |
| QNCX | March 31, 2026 | 189,122 | $633,559 | 34147.5% |
| TNYA | June 30, 2026 | 915,705 | $631,836 | -2.8% |
| RANI | June 30, 2025 | 448,492 | $565,100 | 67.5% |
| ALEC | Dec. 31, 2025 | 175,866 | $520,563 | 55.8% |
| FULC | March 31, 2026 | 14,262 | $161,303 | -49.5% |
| RGEN | March 31, 2026 | 383 | $62,758 | 52.9% |
| HLTHQ | March 31, 2025 | 27,000 | $0 | No longer tracked |
| NVTAQ | March 31, 2025 | 235,606 | $0 | No longer tracked |